Literature DB >> 31427303

Cholic Acid-Peptide Conjugates as Potent Antimicrobials against Interkingdom Polymicrobial Biofilms.

Siddhi Gupta1, Jyoti Thakur2, Sanjay Pal3,4, Ragini Gupta3, Deepakkumar Mishra3, Sandeep Kumar3,5, Kavita Yadav3,5, Amandeep Saini6, Prabhu S Yavvari2, Madhukar Vedantham3, Archana Singh7, Aasheesh Srivastava2, Rajendra Prasad6, Avinash Bajaj1.   

Abstract

Interkingdom polymicrobial biofilms formed by Gram-positive Staphylococcus aureus and Candida albicans pose serious threats of chronic systemic infections due to the absence of any common therapeutic target for their elimination. Herein, we present the structure-activity relationship (SAR) of membrane-targeting cholic acid-peptide conjugates (CAPs) against Gram-positive bacterial and fungal strains. Structure-activity investigations validated by mechanistic studies revealed that valine-glycine dipeptide-derived CAP 3 was the most effective broad-spectrum antimicrobial against S. aureus and C. albicans CAP 3 was able to degrade the preformed single-species and polymicrobial biofilms formed by S. aureus and C. albicans, and CAP 3-coated materials prevented the formation of biofilms. Murine wound and catheter infection models further confirmed the equally potent bactericidal and fungicidal effect of CAP 3 against bacterial, fungal, and polymicrobial infections. Taken together, these results demonstrate that CAPs, as potential broad-spectrum antimicrobials, can effectively clear the frequently encountered polymicrobial infections and can be fine-tuned further for future applications.
Copyright © 2019 American Society for Microbiology.

Entities:  

Keywords:  antibacterial; antifungal; antimicrobials; bile acids; biofilms; membrane targeting

Mesh:

Substances:

Year:  2019        PMID: 31427303      PMCID: PMC6811435          DOI: 10.1128/AAC.00520-19

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  56 in total

Review 1.  Prevention and control of biofilm-based medical-device-related infections.

Authors:  Iolanda Francolini; Gianfranco Donelli
Journal:  FEMS Immunol Med Microbiol       Date:  2010-03-03

Review 2.  Bacterial and fungal biofilm infections.

Authors:  A Simon Lynch; Gregory T Robertson
Journal:  Annu Rev Med       Date:  2008       Impact factor: 13.739

3.  Comparison of in vivo optical systems for bioluminescence and fluorescence imaging.

Authors:  Steven K Cool; Koen Breyne; Evelyne Meyer; Stefaan C De Smedt; Niek N Sanders
Journal:  J Fluoresc       Date:  2013-04-12       Impact factor: 2.217

4.  Membrane active vancomycin analogues: a strategy to combat bacterial resistance.

Authors:  Venkateswarlu Yarlagadda; Padma Akkapeddi; Goutham B Manjunath; Jayanta Haldar
Journal:  J Med Chem       Date:  2014-05-20       Impact factor: 7.446

5.  Assessment and interpretation of bacterial viability by using the LIVE/DEAD BacLight Kit in combination with flow cytometry.

Authors:  Michael Berney; Frederik Hammes; Franziska Bosshard; Hans-Ulrich Weilenmann; Thomas Egli
Journal:  Appl Environ Microbiol       Date:  2007-03-23       Impact factor: 4.792

6.  Fatty Acid Comprising Lysine Conjugates: Anti-MRSA Agents That Display In Vivo Efficacy by Disrupting Biofilms with No Resistance Development.

Authors:  Mohini M Konai; Jayanta Haldar
Journal:  Bioconjug Chem       Date:  2017-03-06       Impact factor: 4.774

7.  Structure-Activity Relationship of Amino Acid Tunable Lipidated Norspermidine Conjugates: Disrupting Biofilms with Potent Activity against Bacterial Persisters.

Authors:  Mohini M Konai; Utsarga Adhikary; Sandip Samaddar; Chandradhish Ghosh; Jayanta Haldar
Journal:  Bioconjug Chem       Date:  2015-10-30       Impact factor: 4.774

8.  Patterns of amphotericin B killing kinetics against seven Candida species.

Authors:  Emilia Cantón; Javier Pemán; Miguel Gobernado; Angel Viudes; Ana Espinel-Ingroff
Journal:  Antimicrob Agents Chemother       Date:  2004-07       Impact factor: 5.191

9.  Critical aspects of using bacterial cell viability assays with the fluorophores SYTO9 and propidium iodide.

Authors:  Philipp Stiefel; Sabrina Schmidt-Emrich; Katharina Maniura-Weber; Qun Ren
Journal:  BMC Microbiol       Date:  2015-02-18       Impact factor: 3.605

10.  Candida albicans Mycofilms Support Staphylococcus aureus Colonization and Enhances Miconazole Resistance in Dual-Species Interactions.

Authors:  Ryan Kean; Ranjith Rajendran; Jennifer Haggarty; Eleanor M Townsend; Bryn Short; Karl E Burgess; Sue Lang; Owain Millington; William G Mackay; Craig Williams; Gordon Ramage
Journal:  Front Microbiol       Date:  2017-02-23       Impact factor: 5.640

View more
  6 in total

Review 1.  In it together: Candida-bacterial oral biofilms and therapeutic strategies.

Authors:  Geelsu Hwang
Journal:  Environ Microbiol Rep       Date:  2022-02-26       Impact factor: 3.541

2.  Cholyl 1,3,4-oxadiazole hybrid compounds: design, synthesis and antimicrobial assessment.

Authors:  Anas J Rasras; Mohamed El-Naggar; Nesreen A Safwat; Raed A Al-Qawasmeh
Journal:  Beilstein J Org Chem       Date:  2022-05-31       Impact factor: 2.544

3.  N-methyl Benzimidazole Tethered Cholic Acid Amphiphiles Can Eradicate S. aureus-Mediated Biofilms and Wound Infections.

Authors:  Himanshu Kakkar; Nalini Chaudhary; Devashish Mehta; Varsha Saini; Shallu Maheshwari; Jitender Singh; Preeti Walia; Avinash Bajaj
Journal:  Molecules       Date:  2022-05-30       Impact factor: 4.927

Review 4.  Recent Advances and Opportunities in the Study of Candida albicans Polymicrobial Biofilms.

Authors:  Carolina H Pohl
Journal:  Front Cell Infect Microbiol       Date:  2022-02-18       Impact factor: 5.293

Review 5.  Candida albicans and Staphylococcus Species: A Threatening Twosome.

Authors:  Hans Carolus; Katrien Van Dyck; Patrick Van Dijck
Journal:  Front Microbiol       Date:  2019-09-18       Impact factor: 5.640

Review 6.  Strategies and Approaches for Discovery of Small Molecule Disruptors of Biofilm Physiology.

Authors:  Michael A Trebino; Rahul D Shingare; John B MacMillan; Fitnat H Yildiz
Journal:  Molecules       Date:  2021-07-29       Impact factor: 4.411

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.